Published in Cancer Weekly, February 13th, 1995
Pennsylvanian researchers Anna Lokshin et al. investigated the mechanism of interferon beta (IFN(beta)) on squamous differentiation and/or programmed cell death in cultured non-small-cell lung cancer (NSCLC) ("Mechanism of Interferon Beta-Induced Squamous Differentiation and Programmed Cell Death in Human Non-Small-Cell Lung Cancer Lines," Journal of the National Cancer Institute, February 1, 1995, 87(3):206-12).
The authors used three NSCLC cell lines for their study: NCI-H226 (squamous), NCI-H596...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.